Login
Related Links
Special News Items
- Scientists Restore Limited Vision in Blind Patients Using Gene Therapy
- Ultragenyx gets FDA approval for rare disease gene therapy
- Gene therapy shows benefits in all participants in Fabry clinical trial
- Chinese scientist faces probe after girl, 6, dies ‘following experimental gene therapy’
- FDA Approves Sickle Cell Gene Therapy for Young Kids
- First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicine
- Fractyl Health starts first GLP-1 gene therapy trial to reshape diabetes care
- Gene Therapy Breakthrough Offers Hope for Epilepsy Patients
- Ultragenyx's Gene Therapy Study Shows Ammonia Reduction In Rare Metabolic Disorder
- FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
- Drinkable gene therapy foam for the treatment of constrictive esophageal carcinoma
- First patient in Wales receives ground-breaking gene therapy treatment
- Workshop: Cell and Gene Therapy for Rare Diseases 2026
- Groundbreaking gene therapy gives hope to kids with Hunter syndrome
- Gene therapy delivers lasting immune protection in children with rare disorder
- Preliminary but promising gene therapy shows 75% reduction in Huntington's disease progression
- Ultragenyx announces longer-term result from DTX401 AAV gene therapy study
- FDA extends review of Regenxbio's MPS II gene therapy to assess longer-term data
- EMA Issues Negative Opinion for Sarepta’s Gene Therapy Elevidys
- Gene therapy reduces stroke risk factors in sickle cell disease patients
- Second Patient Death After Gene Therapy: Implications For The Future
- A virus based vaccine combined with IL12 gene therapy eradicates aggressive melanoma
- FDA approves Abeona’s epidermolysis bullosa gene therapy Zevaskyn
- New gene therapy drug approved for use in China
- Comprehensive AAV delivery map aids in advancing gene therapy
- Pfizer Drops Approved Hemophilia B Gene Therapy
- Hemophilia B Gene Therapy Achieves Sustained Benefit Over 4 Years
- NHS Approves Landmark Gene Therapy For Sickle Cell Disease
- Novartis’ investigational spinal muscular atrophy gene therapy shows promise in late-stage study
- India’s first gene therapy offers new hope for haemophilia patients
